Temazepam
Active ingredient: Temazepam
In short: Temazepam Capsules, USP are indicated for the short-term treatment of insomnia (generally 7 to 10 days). For patients with short-term insomnia, instructions in the prescription should indicate that Temazepam Capsules should be used for short periods of time (7 to 10 days).
What is Temazepam used for?
Temazepam Capsules, USP are indicated for the short-term treatment of insomnia (generally 7 to 10 days). For patients with short-term insomnia, instructions in the prescription should indicate that Temazepam Capsules should be used for short periods of time (7 to 10 days).
The clinical trials performed in support of efficacy were 2 weeks in duration with the final formal assessment of sleep latency performed at the end of treatment.
âš Boxed warning (FDA's strongest warning)
Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs in patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation.
The use of benzodiazepines, including temazepam, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Abuse and misuse of benzodiazepines commonly involve concomitant use of other medications, alcohol, and/or illicit substances, which is associated with an increased frequency of serious adverse outcomes. Before prescribing temazepam and throughout treatment, assess each patient’s risk for abuse, misuse, and addiction .
The continued use of benzodiazepines, including Temazepam, may lead to clinically significant physical dependence. The risks of dependence and withdrawal increase with longer treatment duration and higher daily dose. Abrupt discontinuation or rapid dosage reduction of temazepam after continued use may precipitate acute withdrawal reactions, which can be life-threatening. To reduce the risk of withdrawal reactions, use a gradual taper to discontinue temazepam or reduce the dosage .
Risks from Concomitant Use with Opioids
Concomitant use of benzodiazepines, including Temazepam, and opioids may result in profound sedation, respiratory depression, coma, and death. …
Temazepam dosage
While the recommended usual adult dose is 15 mg before retiring, 7.5 mg may be sufficient for some patients, and others may need 30 mg. In transient insomnia, a 7.5 mg dose may be sufficient to improve sleep latency. In elderly or debilitated patients, it is recommended that therapy be initiated with 7.5 mg until individual responses are determined.
Discontinuation or Dosage Reduction of Temazepam Capsules
To reduce the risk of withdrawal reactions, use a gradual taper to discontinue temazepam or reduce the dosage. If a patient develops withdrawal reactions, consider pausing the taper or increasing the dosage to the previous tapered dosage level. Subsequently decrease the dosage more slowly .
How to take Temazepam — instructions & advice from the label
TEMAZEPAM (tem az' e pam) Capsules, C-IV
What is the most important information I should know about temazepam?
temazepam
is a benzodiazepine medicine. Taking benzodiazepines with opioid medicines, alcohol, or other central nervous system depressants (including street drugs) can cause severe drowsiness, breathing problems (respiratory depression), coma and death.Get emergency help right away if any of the following happens:
shallow or slowed breathing
breathing stops (which may lead to the heart stopping)
excessive sleepiness (sedation)
Do not drive or operate heavy machinery until you know how taking temazepam and opioids affects you.
Risk of abuse, misuse, and addiction. There is a risk of abuse, misuse, and addiction with benzodiazepines including temazepam which can lead to overdose and serious side effects including coma and death.
Serious side effects including coma and death have happened in people who have abused or misused benzodiazepines, including temazepam. These serious side effects may also include delirium, paranoia, suicidal thoughts or actions, seizures, and difficulty breathing. …
Warnings & precautions
Since the risk of the development of oversedation, dizziness, confusion, and/or ataxia increases substantially with larger doses of benzodiazepines in elderly and debilitated patients, 7.5 mg of temazepam is recommended as the initial dosage for such patients.
Temazepam should be administered with caution in severely depressed patients or those in whom there is any evidence of latent depression; it should be recognized that suicidal tendencies may be present and protective measures may be necessary.
The usual precautions should be observed in patients with impaired renal or hepatic function and in patients with chronic pulmonary insufficiency.
If temazepam is to be combined with other drugs having known hypnotic properties or CNS-depressant effects, consideration should be given to potential additive effects.
The possibility of a synergistic effect exists with the co-administration of temazepam and diphenhydramine. One case of stillbirth at term has been reported 8 hours after a pregnant patient received temazepam and diphenhydramine. A cause and effect relationship has not yet been determined
Advise the patient to read the FDA approved patient labeling (Medication Guide).Risks from Concomitant Use with OpioidsAdvise both patients and caregivers about the risks of potentially fatal respiratory depression and sedation when temazepam is used with opioids and not to use such drugs concomitantly unless supervised by a healthcare provider. …
Temazepam side effects
During controlled clinical studies in which 1076 patients received temazepam at bedtime, the drug was well tolerated. Side effects were usually mild and transient. Adverse reactions occurring in 1% or more of patients are presented in the following table:
Temazepam % Incidence (n=1076) | Placebo % Incidence (n=783)
Drowsiness | 9.1 | 5.6
Headache | 8.5 | 9.1
Fatigue | 4.8 | 4.7
Nervousness | 4.6 | 8.2
Lethargy | 4.5 | 3.4
Dizziness | 4.5 | 3.3
Nausea | 3.1 | 3.8
Hangover | 2.5 | 1.1
Anxiety | 2.0 | 1.5
Depression | 1.7 | 1.8
Dry Mouth | 1.7 | 2.2
Diarrhea | 1.7 | 1.1
Abdominal Discomfort | 1.5 | 1.9
Euphoria | 1.5 | 0.4
Weakness | 1.4 | 0.9
Confusion | 1.3 | 0.5
Blurred Vision | 1.3 | 1.3
Nightmares | 1.2 | 1.7
Vertigo | 1.2 | 0.8
The following adverse events have been reported less frequently (0.5% to 0.9%):
Central Nervous System
- anorexia, ataxia, equilibrium loss, tremor, increased dreaming
Cardiovascular
- dyspnea, palpitations
Gastrointestinal
– vomiting
Musculoskeletal
– backache
Special Senses
- hyperhidrosis, burning eyes
Amnesia, hallucinations, horizontal nystagmus, and paradoxical reactions including restlessness, overstimulation and agitation were rare (less than 0.5%).
About this medicine
Temazepam is a benzodiazepine hypnotic agent. The chemical name is 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1, 4-benzodiazepin-2-one, and the structural formula is:
C
16
H
13
ClN
2
O
2
MW = 300.74
Temazepam is a white, crystalline substance, very slightly soluble in water and sparingly soluble in alcohol USP.
Temazepam capsules, 7.5 mg, 15 mg, 22.5 mg and 30 mg, are for oral administration.
7.5 mg, 15 mg, 22.5 mg and 30 mg Capsules
Active Ingredient: temazepam USP
7.5 mg Capsules
Inactive Ingredients: Corn starch, lactose anhydrous, magnesium stearate, sodium lauryl sulfate, FD&C Red #40 and titanium dioxide.
May also include: sodium lauryl sulfate. Imprinting ink may contain ammonium hydroxide, ethanol, isopropyl alcohol, butanol, shellac, potassium hydroxide, propylene glycol, and black iron oxide.
15 mg Capsules
Inactive Ingredients: Corn starch, lactose anhydrous, magnesium stearate, sodium lauryl sulfate, FD&C Blue #1, FD&C yellow # 6, gelatin and titanium dioxide.
May also include: sodium lauryl sulfate. …
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 0e752dda-f00f-4123-b59f-aa911b897a5a. Read the full official label on DailyMed.
Related medicines
Tirzepatide Buspirone Venlafaxine Zolpidem Citalopram Lorazepam Melatonin Triazolam